Carbon Neutrality Goals
• GOALS
We are committed to achieving carbon neutrality by 2030. We plan to increase the proportion of renewable energy and continuously improve the energy structure.
In the future, we will take the perspective of the entire value chain life cycle, focus on renewable energy opportunities, energy-saving technology transformation, green supply chain construction and other aspects, actively respond to the challenges of climate change, and reduce the impact of greenhouse gas emissions on the human environment.
About Aurisco
Aurisco serves global markets with over 25 years’ experience in the development and cGMP manufacture of Active Pharmaceutical Ingredients. With 6 R&D centers, 3 FDA inspected sites and building its 4th site in China, and sales offices in USA, Portugal, India and Brazil, the company focuses on complex products for the most demanding customers in the most regulated markets. With a broad portfolio of complex generic APIs, the company is broadening its offer from small molecules to peptides and oligonucleotides and offering innovators an IP safe and cGMP and ESG compliant environment for research, development and manufacturing of their innovative molecules. With over 80 patents filled worldwide and 250 scientists, the company pays special attention to IP, innovation and sustainability.
Being Ecovadis ranked, Aurisco has joined the SBTi, M2030 and the Sustainable Procurement Pledge. Aurisco was the first pharmaceutical company in China to pass a RX360 supply chain security inspection and has been audited by the Pharmaceutical Supply Chain Initiative (PSCI), a group of pharmaceutical and healthcare companies who share a vision of better social, health, safety and environmental outcomes in the communities where they buy. www.bsm2018.com.
Follow Aoruite WeChat official account
